An altered immune profile was ascertained in the PB of lymphoma patients characterized by a lower percentage of regulatory NK and CD3+ T-cells, while a significant increase in PMN-MDSCs (CD11b+HLADRdimCD33+CD14−) was observed. This evidence concerns the gene CD14 and lymphoma.